Treatment of Retinal Vein Occlusion with Ranibizumab in Clinical Practice: Longer-Term Results and Predictive Factors of Functional Outcome
Author(s) -
Cláudia Farinha,
João Pedro Marques,
Elisabete Almeida,
Alda S. Baltar,
Ana Rita Santos,
Pedro Melo,
Miguel Costa,
João Figueira,
Maria Luz Cachulo,
Isabel Pires,
Rufino Silva
Publication year - 2015
Publication title -
ophthalmic research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.893
H-Index - 54
eISSN - 1423-0259
pISSN - 0030-3747
DOI - 10.1159/000440848
Subject(s) - medicine , ranibizumab , macular edema , ophthalmology , retinal vein , visual acuity , central retinal vein occlusion , fluorescein angiography , occlusion , branch retinal vein occlusion , retinal , surgery , bevacizumab , chemotherapy
To evaluate long-term results and predictors of efficacy in patients with macular edema due to retinal vein occlusion (RVO) treated with intravitreal ranibizumab in a clinical practice setting.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom